Design and validation of a novel multi-epitopes vaccine against hantavirus

References

• Albaqami, F. F., Altharawi, A., Althurwi, H. N., Alharthy, K. M., Qasim, M., Muhseen, Z. T., & Ul Qamar, M. (2023). Computational modeling and evaluation of potential mRNA and peptide-based vaccine against Marburg Virus (MARV) to provide immune protection against hemorrhagic fever. BioMed Research International, 2023, 5560605. https://doi.org/10.1155/2023/5560605
   PubMed Web of Science ®Google Scholar
• Alharbi, M., Alshammari, A., Alasmari, A. F., Alharbi, S., Ul Qamar, M., Abbasi, S. W., Shaker, B., & Ahmad, S. (2022). Whole proteome-based therapeutic targets annotation and designing of multi-epitope-based vaccines against the gram-negative XDR-Alcaligenes faecalis bacterium. Vaccines, 10(3), 462. https://doi.org/10.3390/vaccines10030462
   Web of Science ®Google Scholar
• Alshammari, A., Alharbi, M., Alghamdi, A., Alharbi, S. A., Ashfaq, U. A., Tahir Ul Qamar, M., Ullah, A., Irfan, M., Khan, A., & Ahmad, S. (2022). Computer-aided multi-epitope vaccine design against Enterobacter xiangfangensis. International Journal of Environmental Research and Public Health, 19(13), 7723. https://doi.org/10.3390/ijerph19137723
   PubMed Web of Science ®Google Scholar
• Althurwi, H. N., Alharthy, K. M., Albaqami, F. F., Altharawi, A., Javed, M. R., Muhseen, Z. T., & Ul Qamar, M. (2022). mRNA-based vaccine designing against Epstein-Barr virus to induce an immune response using immunoinformatic and molecular modelling approaches. International Journal of Environmental Research and Public Health, 19(20), 13054. https://doi.org/10.3390/ijerph192013054
   PubMed Web of Science ®Google Scholar
• Andrusier, N., Nussinov, R., & Wolfson, H. J. (2007). FireDock: Fast interaction refinement in molecular docking. Proteins, 69(1), 139–159. https://doi.org/10.1002/prot.21495
   PubMed Web of Science ®Google Scholar
• Antonio-Herrera, L., Badillo-Godinez, O., Medina-Contreras, O., Tepale-Segura, A., García-Lozano, A., Gutierrez-Xicotencatl, L., Soldevila, G., Esquivel-Guadarrama, F. R., Idoyaga, J., & Bonifaz, L. C. (2018). The nontoxic cholera B subunit is a potent adjuvant for intradermal DC-targeted vaccination. Frontiers in Immunology, 9, 2212. https://doi.org/10.3389/fimmu.2018.02212
   PubMed Web of Science ®Google Scholar
• Barker, J., daSilva, L. L. P., & Crump, C. M. (2023). Mechanisms of bunyavirus morphogenesis and egress. Journal of General Virology, 104(4), 1845. https://doi.org/10.1099/jgv.0.001845
   Web of Science ®Google Scholar
• Behmard, E., Abdulabbas, H. T., Abdalkareem Jasim, S., Najafipour, S., Ghasemian, A., Farjadfar, A., Barzegari, E., Kouhpayeh, A., & Abdolmaleki, P. (2022). Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach. PloS One, 17(8), e0272582. https://doi.org/10.1371/journal.pone.0272582
   PubMed Web of Science ®Google Scholar
• Blast, N. (2015). Basic local alignment search tool. National Library of Medicine: National Center for Biotechnology Information.
   Google Scholar
• Bonilla, F. A., & Oettgen, H. C. (2010). Adaptive immunity. The Journal of Allergy and Clinical Immunology, 125(2 Suppl 2), S33–S40. https://doi.org/10.1016/j.jaci.2009.09.017
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., III, Darden, T., Gohlke, H., Luo, R., Merz, Jr, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. https://doi.org/10.1002/jcc.20290
   PubMed Web of Science ®Google Scholar
• Chatterjee, D., Al Rimon, R., Chowdhury, U. F., & Islam, M. R. (2023). A multi-epitope based vaccine against the surface proteins expressed in cyst and trophozoite stages of parasite Entamoeba histolytica. Journal of Immunological Methods, 517, 113475. https://doi.org/10.1016/j.jim.2023.113475
   PubMed Web of Science ®Google Scholar
• Chen, J. J., Guo, T. C., Song, S. X., Shao, Z. J., & Liu, K. (2020). Epidemiological characteristics and the development of spatiotemporal analysis models on hemorrhagic fever with renal syndrome in China. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, 41(10), 1735–1740.
   PubMedGoogle Scholar
• Cheng, J., Randall, A. Z., Sweredoski, M. J., & Baldi, P. (2005). SCRATCH: A protein structure and structural feature prediction server. Nucleic Acids Research, 33(Web Server issue), W72–W76. https://doi.org/10.1093/nar/gki396
   PubMedGoogle Scholar
• De Vries, S. J., Van Dijk, A. D. J., Krzeminski, M., van Dijk, M., Thureau, A., Hsu, V., Wassenaar, T., & Bonvin, A. M. J. J. (2007). HADDOCK versus HADDOCK: New features and performance of HADDOCK2. 0 on the CAPRI targets. Proteins, 69(4), 726–733. https://doi.org/10.1002/prot.21723
   PubMed Web of Science ®Google Scholar
• Dey, J., Mahapatra, S. R., Singh, P. K., Prabhuswamimath, S. C., Misra, N., & Suar, M. (2023). Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction–based approaches. Immunologic Research, 1–24. https://doi.org/10.1007/s12026-023-09374-4
   Web of Science ®Google Scholar
• Dombkowski, A. A., Sultana, K. Z., & Craig, D. B. (2014). Protein disulfide engineering. FEBS Letters, 588(2), 206–212. https://doi.org/10.1016/j.febslet.2013.11.024
   PubMed Web of Science ®Google Scholar
• Ermonval, M., Baychelier, F., & Tordo, N. (2016). What do we know about how hantaviruses interact with their different hosts? Viruses, 8(8), 223. https://doi.org/10.3390/v8080223
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Goeijenbier, M., Aron, G., Anfasa, F., Lundkvist, Å., Verner-Carlsson, J., Reusken, C. B. E. M., Martina, B. E. E., van Gorp, E. C. M., & Resida, L. (2015). Emerging viruses in the Republic of Suriname: Retrospective and prospective study into chikungunya circulation and suspicion of Human Hantavirus Infections, 2008–2012 and 2014. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.), 15(10), 611–618. https://doi.org/10.1089/vbz.2015.1798
   PubMed Web of Science ®Google Scholar
• Goumari, M. M., Farhani, I., Nezafat, N., & Mahmoodi, S. (2020). Multi-epitope vaccines (MEVs), as a novel strategy against infectious diseases. Current Proteomics, 17(5), 354–364. https://doi.org/10.2174/1570164617666190919120140
   Web of Science ®Google Scholar
• Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., & Raghava, G. P. S. (2015). Peptide toxicity prediction. In Computational peptidology (pp. 143–157). Springer.
   Google Scholar
• Heo, L., Park, H., & Seok, C. (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41(Web Server issue), W384–W388. https://doi.org/10.1093/nar/gkt458
   PubMed Web of Science ®Google Scholar
• Hooper, J. W., Josleyn, M., Ballantyne, J., & Brocato, R. (2013). A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine, 31(40), 4314–4321. https://doi.org/10.1016/j.vaccine.2013.07.025
   PubMed Web of Science ®Google Scholar
• Ikram, A., Alzahrani, B., Zaheer, T., Sattar, S., Rasheed, S., Aurangzeb, M., & Ishaq, Y. (2023). An in silico deep learning approach to multi-epitope vaccine design: a hepatitis E virus case study. Vaccines, 11(3), 710. https://doi.org/10.3390/vaccines11030710
   Web of Science ®Google Scholar
• Ismail, S., Ahmad, S., & Azam, S. S. (2020). Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens. European Journal of Pharmaceutical Sciences: official Journal of the European Federation for Pharmaceutical Sciences, 146, 105258. https://doi.org/10.1016/j.ejps.2020.105258
   PubMed Web of Science ®Google Scholar
• Ismail, S., Alsowayeh, N., Abbasi, H. W., Albutti, A., Ul Qamar, M., Ahmad, S., Raza, R. Z., Sadia, K., & Abbasi, S. W. (2022). Pan-genome-assisted computational design of a multi-epitopes-based vaccine candidate against Helicobacter cinaedi. International Journal of Environmental Research and Public Health, 19(18), 11579. https://doi.org/10.3390/ijerph191811579
   PubMed Web of Science ®Google Scholar
• Jespersen, M. C., Peters, B., Nielsen, M., & Marcatili, P. (2017). BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Research, 45(W1), W24–W29. https://doi.org/10.1093/nar/gkx346
   PubMed Web of Science ®Google Scholar
• Jonsson, C. B., Figueiredo, L. T. M., & Vapalahti, O. (2010). A global perspective on hantavirus ecology, epidemiology, and disease. Clinical Microbiology Reviews, 23(2), 412–441. https://doi.org/10.1128/CMR.00062-09
   PubMed Web of Science ®Google Scholar
• Joshi, A., Ray, N. M., Singh, J., Upadhyay, A. K., & Kaushik, V. (2022). T-cell epitope-based vaccine designing against Orthohantavirus: A causative agent of deadly cardio-pulmonary disease. Network Modeling and Analysis in Health Informatics and Bioinformatics, 11(1), 2. https://doi.org/10.1007/s13721-021-00339-x
   PubMed Web of Science ®Google Scholar
• Kaliappan, S., & Bombay, I. I. T. (2018). UCSF Chimera-Overview.
   Google Scholar
• Khaiboullina, S. F., Levis, S., Morzunov, S. P., Martynova, E. V., Anokhin, V. A., Gusev, O. A., St Jeor, S. C., Lombardi, V. C., & Rizvanov, A. A. (2017). Serum cytokine profiles differentiating hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Frontiers in Immunology, 8, 567. https://doi.org/10.3389/fimmu.2017.00567
   PubMed Web of Science ®Google Scholar
• Khan, A., Khan, M., Ullah, S., & Wei, D.-Q. (2021). Hantavirus: The next pandemic we are waiting for? Interdisciplinary Sciences, Computational Life Sciences, 13(1), 147–152. https://doi.org/10.1007/s12539-020-00413-4
   PubMed Web of Science ®Google Scholar
• Koehler, F. C., Di Cristanziano, V., Späth, M. R., Hoyer-Allo, K. J. R., Wanken, M., Müller, R.-U., & Burst, V. (2022). The kidney in hantavirus infection—Epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management. Clinical Kidney Journal, 15(7), 1231–1252. https://doi.org/10.1093/ckj/sfac008
   PubMed Web of Science ®Google Scholar
• Kruger, D. H., Figueiredo, L. T. M., Song, J.-W., & Klempa, B. (2015). Hantaviruses—Globally emerging pathogens. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology, 64, 128–136. https://doi.org/10.1016/j.jcv.2014.08.033
   PubMed Web of Science ®Google Scholar
• Liu, R., Ma, H., Shu, J., Zhang, Q., Han, M., Liu, Z., Jin, X., Zhang, F., & Wu, X. (2019). Vaccines and therapeutics against hantaviruses. Frontiers in Microbiology, 10, 2989. https://doi.org/10.3389/fmicb.2019.02989
   PubMed Web of Science ®Google Scholar
• MacNeil, A., Ksiazek, T. G., & Rollin, P. E. (2011). Hantavirus pulmonary syndrome, United States, 1993–2009. Emerging Infectious Diseases, 17(7), 1195–1201. https://doi.org/10.3201/eid1707.101306
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Malonis, R. J., Lai, J. R., & Vergnolle, O. (2020). Peptide-based vaccines: current progress and future challenges. Chemical Reviews, 120(6), 3210–3229. https://doi.org/10.1021/acs.chemrev.9b00472
   PubMed Web of Science ®Google Scholar
• Mayor, J., Engler, O., & Rothenberger, S. (2021). Antiviral efficacy of ribavirin and favipiravir against hantaan virus. Microorganisms, 9(6), 1306. https://doi.org/10.3390/microorganisms9061306
   PubMed Web of Science ®Google Scholar
• McDonald, B. D., Bunker, J. J., Erickson, S. A., Oh-Hora, M., & Bendelac, A. (2015). Crossreactive $α$$β$T cell receptors are the predominant targets of thymocyte negative selection. Immunity, 43(5), 859–869. https://doi.org/10.1016/j.immuni.2015.09.009
   PubMed Web of Science ®Google Scholar
• Meier, K., Thorkelsson, S. R., Quemin, E. R. J., & Rosenthal, M. (2021). Hantavirus replication cycle—An updated structural virology perspective. Viruses, 13(8), 1561. https://doi.org/10.3390/v13081561
   PubMed Web of Science ®Google Scholar
• Milholland, M. T., Castro-Arellano, I., Suzán, G., Garcia-Peña, G. E., Lee, T. E., Rohde, R. E., Alonso Aguirre, A., & Mills, J. N. (2018). Global diversity and distribution of hantaviruses and their hosts. EcoHealth, 15(1), 163–208. https://doi.org/10.1007/s10393-017-1305-2
   PubMed Web of Science ®Google Scholar
• Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Munir, N., Jahangeer, M., Hussain, S., Mahmood, Z., Ashiq, M., Ehsan, F., Akram, M., Ali Shah, S. M., Riaz, M., & Sana, A. (2021). Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: A review. Clinical and Experimental Pharmacology and Physiology, 48(1), 20–34. https://doi.org/10.1111/1440-1681.13403
   PubMed Web of Science ®Google Scholar
• Muranyi, W., Bahr, U., Zeier, M., & van der Woude, F. J. (2005). Hantavirus infection. Journal of the American Society of Nephrology: JASN, 16(12), 3669–3679. https://doi.org/10.1681/ASN.2005050561
   PubMed Web of Science ®Google Scholar
• Naz, A., Awan, F. M., Obaid, A., Muhammad, S. A., Paracha, R. Z., Ahmad, J., & Ali, A. (2015). Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: A reverse vaccinology based approach. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 32, 280–291. https://doi.org/10.1016/j.meegid.2015.03.027
   PubMed Web of Science ®Google Scholar
• Ong, E., Cooke, M. F., Huffman, A., Xiang, Z., Wong, M. U., Wang, H., Seetharaman, M., Valdez, N., & He, Y. (2021). Vaxign2: The second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning. Nucleic Acids Research, 49(W1), W671–W678. https://doi.org/10.1093/nar/gkab279
   PubMed Web of Science ®Google Scholar
• Papa, A. (2012). Dobrava-Belgrade virus: Phylogeny, epidemiology, disease. Antiviral Research, 95(2), 104–117. https://doi.org/10.1016/j.antiviral.2012.05.011
   PubMed Web of Science ®Google Scholar
• Papa, A., Vaheri, A., LeDuc, J. W., Krüger, D. H., Avšič-Županc, T., Arikawa, J., Song, J.-W., Markotić, A., Clement, J., Liang, M., Li, D., Yashina, L. N., Jonsson, C. B., & Schmaljohn, C. S. (2016). Meeting report: Tenth international conference on hantaviruses. Antiviral Research, 133, 234–241. https://doi.org/10.1016/j.antiviral.2016.08.015
   PubMed Web of Science ®Google Scholar
• Perales-Linares, R., & Navas-Martin, S. (2013). Toll-like receptor 3 in viral pathogenesis: Friend or foe? Immunology, 140(2), 153–167. https://doi.org/10.1111/imm.12143
   PubMed Web of Science ®Google Scholar
• Plyusnin, A., Vapalahti, O., & Vaheri, A. (1996). Hantaviruses: Genome structure, expression and evolution. Journal of General Virology, 77(11), 2677–2687. https://doi.org/10.1099/0022-1317-77-11-2677
   PubMedGoogle Scholar
• Pollard, A. J., & Bijker, E. M. (2021). A guide to vaccinology: From basic principles to new developments. Nature Reviews Immunology, 21 (2), 83–100. https://doi.org/10.1038/s41577-020-00479-7
   PubMed Web of Science ®Google Scholar
• Ponomarenko, J., Bui, H.-H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., & Peters, B. (2008). ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics, 9(1), 1–8. https://doi.org/10.1186/1471-2105-9-514
   PubMedGoogle Scholar
• Rappuoli, R. (2001). Reverse vaccinology, a genome-based approach to vaccine development. Vaccine, 19(17-19), 2688–2691. https://doi.org/10.1016/s0264-410x(00)00554-5
   PubMed Web of Science ®Google Scholar
• Rehman, A., Ahmad, S., Shahid, F., Albutti, A., Alwashmi, A. S. S., Aljasir, M. A., Alhumeed, N., Qasim, M., Ashfaq, U. A., & Tahir Ul Qamar, M. (2021). Integrated core proteomics, subtractive proteomics, and immunoinformatics investigation to unveil a potential multi-epitope vaccine against Schistosomiasis. Vaccines, 9(6), 658. https://doi.org/10.3390/vaccines9060658
   Web of Science ®Google Scholar
• Reynes, J.-M., Carli, D., Bour, J.-B., Boudjeltia, S., Dewilde, A., Gerbier, G., Nussbaumer, T., Jacomo, V., Rapt, M.-P., Rollin, P. E., & Septfons, A. (2017). Seoul virus infection in humans, France, 2014–2016. Emerging Infectious Diseases, 23(6), 973–977. https://doi.org/10.3201/eid2306.160927
   PubMed Web of Science ®Google Scholar
• Reynolds, M. M., & Theodore, L. (2023). A guide to virology for engineers and applied scientists: epidemiology, emergency management, and optimization. John Wiley & Sons.
   Google Scholar
• Rida, T., Ahmad, S., Ullah, A., Ismail, S., Tahir Ul Qamar, M., Afsheen, Z., Khurram, M., Saqib Ishaq, M., Alkhathami, A. G., Alatawi, E. A., Alrumaihi, F., & Allemailem, K. S. (2022). Pan-genome analysis of oral bacterial pathogens to predict a potential novel multi-epitopes vaccine candidate. International Journal of Environmental Research and Public Health, 19(14), 8408. https://doi.org/10.3390/ijerph19148408
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. III, (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Sanober, G., Ahmad, S., & Azam, S. S. (2017). Identification of plausible drug targets by investigating the druggable genome of MDR Staphylococcus epidermidis. Gene Reports, 7, 147–153. https://doi.org/10.1016/j.genrep.2017.04.008
   Web of Science ®Google Scholar
• Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005). PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Research, 33(Web Server issue), W363–W367. https://doi.org/10.1093/nar/gki481
   PubMed Web of Science ®Google Scholar
• Schoch, C. L., Ciufo, S., Domrachev, M., Hotton, C. L., Kannan, S., Khovanskaya, R., Leipe, D., Mcveigh, R., O’Neill, K., Robbertse, B., Sharma, S., Soussov, V., Sullivan, J. P., Sun, L., Turner, S., & Karsch-Mizrachi, I. (2020). NCBI Taxonomy: A comprehensive update on curation, resources and tools. Database, 2020 https://doi.org/10.1093/database/baaa062
   Google Scholar
• Schönrich, G., Rang, A., Lütteke, N., Raftery, M. J., Charbonnel, N., & Ulrich, R. G. (2008). Hantavirus-induced immunity in rodent reservoirs and humans. Immunological Reviews, 225(1), 163–189. https://doi.org/10.1111/j.1600-065X.2008.00694.x
   PubMedGoogle Scholar
• Shanthappa, P. M., Suravajhala, R., Suravajhala, P., Kumar, G., & Melethadathil, N. (2022). In silico based multi-epitope vaccine design against norovirus. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2022.2105400
   Google Scholar
• Sironen, T., Vaheri, A., & Plyusnin, A. (2001). Molecular evolution of Puumala hantavirus. Journal of Virology, 75(23), 11803–11810. https://doi.org/10.1128/JVI.75.23.11803-11810.2001
   PubMed Web of Science ®Google Scholar
• Skwarczynski, M., & Toth, I. (2016). Peptide-based synthetic vaccines. Chemical Science, 7(2), 842–854. https://doi.org/10.1039/c5sc03892h
   PubMed Web of Science ®Google Scholar
• Song, J. Y., Woo, H. J., Cheong, H. J., Noh, J. Y., Baek, L. J., & Kim, W. J. (2016). Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (HantavaxTM) in healthy adults. Vaccine, 34(10), 1289–1295. https://doi.org/10.1016/j.vaccine.2016.01.031
   PubMed Web of Science ®Google Scholar
• Stranzl, T., Larsen, M. V., Lundegaard, C., & Nielsen, M. (2010). NetCTLpan: Pan-specific MHC class I pathway epitope predictions. Immunogenetics, 62(6), 357–368. https://doi.org/10.1007/s00251-010-0441-4
   PubMed Web of Science ®Google Scholar
• Sussman, J. L., Lin, D., Jiang, J., Manning, N. O., Prilusky, J., Ritter, O., & Abola, E. E. (1998). Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallographica. Section D, Biological Crystallography, 54(Pt 6 Pt 1), 1078–1084. https://doi.org/10.1107/s0907444998009378
   PubMedGoogle Scholar
• Tariq, M., & Kim, D.-M. (2022). Hemorrhagic fever with renal syndrome: Literature review, epidemiology, clinical picture and pathogenesis. Infection & Chemotherapy, 54(1), 1–19. https://doi.org/10.3947/ic.2021.0148
   PubMed Web of Science ®Google Scholar
• Ullah, A., Shahid, F. A., Haq, M. U., Ul Qamar, M., Irfan, M., Shaker, B., Ahmad, S., Alrumaihi, F., Allemailem, K. S., & Almatroudi, A. (2022). An integrative reverse vaccinology, immunoinformatic, docking and simulation approaches towards designing of multi-epitopes based vaccine against monkeypox virus. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/10.1080/07391102.2022.2125441
   Web of Science ®Google Scholar
• Vercammen, E., Staal, J., & Beyaert, R. (2008). Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clinical Microbiology Reviews, 21(1), 13–25. https://doi.org/10.1128/CMR.00022-07
   PubMed Web of Science ®Google Scholar
• Vita, R., Overton, J. A., Greenbaum, J. A., Ponomarenko, J., Clark, J. D., Cantrell, J. R., Wheeler, D. K., Gabbard, J. L., Hix, D., Sette, A., & Peters, B. (2015). The immune epitope database (IEDB) 3.0. Nucleic Acids Research, 43(Database issue), D405–D412. https://doi.org/10.1093/nar/gku938
   PubMed Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2001). Antechamber: An accessory software package for molecular mechanical calculations. Journal of the American Chemical Society, 222, U403.
   Web of Science ®Google Scholar
• Wang, Y., Wu, W., Negre, N. N., White, K. P., Li, C., & Shah, P. K. (2011). Determinants of antigenicity and specificity in immune response for protein sequences. BMC Bioinformatics, 12(1), 1–13. https://doi.org/10.1186/1471-2105-12-251
   PubMedGoogle Scholar
• Watson, D. C., Sargianou, M., Papa, A., Chra, P., Starakis, I., & Panos, G. (2014). Epidemiology of Hantavirus infections in humans: A comprehensive, global overview. Critical Reviews in Microbiology, 40(3), 261–272. https://doi.org/10.3109/1040841X.2013.783555
   PubMed Web of Science ®Google Scholar
• Zhao, C., Sun, Y., Zhao, Y., Wang, S., Yu, T., Du, F., Yang, X. F., & Luo, E. (2012). Immunogenicity of a multi-epitope DNA vaccine against hantavirus. Human Vaccines & Immunotherapeutics, 8(2), 208–215. https://doi.org/10.4161/hv.18389
   PubMed Web of Science ®Google Scholar